TrialBridge

NCT06922188

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

Recruiting · Not specified · Fred Hutchinson Cancer Center · registry updated 2026-08-19

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

Alzheimer's Disease and related dementias (AD/ADRD) are common and debilitating conditions. Financial hardship, a multidimensional construct of financial strain, financial stress and asset depletion, is common in AD/ADRD due to exorbitant out-of-pocket spending such as for long-term care, lower work productivity and income for their caregivers that can last for decades after disease onset, and difficulty deciding between nursing home care or home-based care while negotiating insurance coverage. People from historically marginalized groups can experience a double disparity with fewer financial resources to manage AD/ADRD and a greater risk of AD/ADRD. Screening for financial hardship in AD/ADRD is key for addressing the needs of patients and caregivers but critical barriers include a lack of suitable screening measures. Current measures are very general and meant for people without chronic medical conditions or are specific to other diseases. To fill this gap, this study will create a suite of measures that can screen for financial hardship in people with AD/ADRD and their families and caregivers....

Inclusion

  • Adults aged 18 years or older
  • One of the following:
  • Clinical diagnosis of Alzheimer's disease or related dementia
  • Being a caregiver to individuals with clinical diagnosis of Alzheimer's disease or related dementia
  • Able to read and speak English or Spanish
  • Able to provide informed consent

Exclusion

  • Cognitive impairment precluding informed consent

Open NCT06922188 on ClinicalTrials.govAll conditions